Dr. Borinstein is the Scott and Tracie Hamilton Chair in Cancer Survivorship in the Division of Pediatric Hematology/Oncology at Vanderbilt University Medical Center. He is the director of the Pediatric Sarcoma and Adolescent and Young Adult (AYA) oncology programs, serves as the Pediatric Hematology/Oncology fellowship Program Director, and is the local institutional principal investigator for the Children's Oncology Group. He is a nationally recognized expert in bone and soft tissue sarcomas and his research and clinical interests are aligned to improve the treatment and outcomes of children, teenagers, and young adults with cancer. In addition to conducting translational research in pediatric sarcomas, highly malignant cancers of bone, muscle, and connective tissue. Dr. Borinstein is involved in the development and implementation of clinical trials for solid tumors and AYA cancer patients, with a goal of integrating new drugs and protocols into our current cancer therapies. Dr. Borinstein also is also actively involved in developing ways to improve supportive care and minimize late effects for AYA patients during and after being treated with cancer.

>> View Publications on PubMed

Dr. Betters' research interests are focused on early mobility, rehabilitation of the ICU patient, sedation, and delirium in critically ill children. She leads the multi-disciplinary ICU Liberation Committee at Monroe Carell Jr. Children’s Hospital at Vanderbilt and recently served as Co-Chair of the Society of Critical Care Medicine’s ICU Liberation Committee. She was an author on the 2022 SCCM Clinical Practice Guidelines on Prevention and Management of Pain, Agitation, Neuromuscular Blockade, and Delirium in Critically Ill Pediatric Patients With Consideration of the ICU Environment and Early Mobility (PANDEM). She was a founding leader of the American Delirium Society Pediatric Special Interest Group, and is member of the Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center and pediatric delirium team at Vanderbilt.

>> View Publications on PubMed

Dr. Benedetti is a solid tumor oncologist focused on care of children with renal tumors, liver tumors, neuroblastoma, and genetic predisposition to cancer. He is on the steering committee of the Children's Oncology Group (COG) Renal Tumor Committee, where he works to develop and conduct clinical trials for children with cancers of the kidney. Dr. Benedetti is also a bioethicist with expertise in ethical issues in pediatrics and pediatric cancer care. His research explores ethical dilemmas that occur in the care of children with cancer, with a current emphasis is on understanding cases where families refuse recommended treatment.

>> View Publications on PubMed

Dr. Bearl's research interests center around clinical outcomes for children with end-stage heart failure specifically patient selection, management and post-transplant outcomes for children who require a ventricular assist device (VAD). Dr. Bearl is actively involved in the international quality improvement initiative related to VAD outcomes called Advanced Cardiac Therapies Improving Outcomes Network (ACTION) and the prospective VAD research registry called Pedimacs, which is the pediatric-specific arm of Intermacs (Interagency Registry for Mechanically Assisted Circulatory Support) managed by the Society of Thoracic Surgeons (STS).

>> View Publications on PubMed

Dr. Banerjee conducts clinical research related to surveillance of antibiotic-resistant bacteria and strategies to optimize appropriate antibiotic use. She is principal investigator on NIH and CDC-funded studies implementing and evaluating rapid diagnostics and other antibiotic stewardship interventions.

>> View Publications on PubMed

>> Learn more about the Antimicrobial Stewardship Program